Umesh - Presentation - Jan 2023

MONTHLY SALES
REVIEW 2 3
2 0
Y
R
A
U
N
J A
S.Umesh
DELTA - E A S T
JANUARY- TARGET VS ACHIEVEMENT
3,060,000
3,040,000 3,038,338
3,020,000
3,000,000
2,980,000 Tar
Ach
2,960,000 2,955,364
2,940,000
2,920,000
2,900,000
June
Target Achievement %
2,955,364 3,038,338 103%
YTD SALES 2023
4,000,000
3,038,338
3,000,000 2,955,364 Tar
Ach
2,000,000
2023
Tar Ach %
2,955,364 3,038,338 103%
JANUARY UNIT WISE SALES
Product Target Achievement Achievement %
Avestalo 10mg 05 10 200%

Empiget 10mg 182 485 266%
Empiget 25mg 30 110 367%
Ezita 10mg 140 178 127%
Gabica 100mg 86 64 74%
Gabica 150mg 264 171 65%
Gabica 50mg 250 218 87%
Gabica 75mg 265 257 97%
Getryl 1mg 268 238 89%
Getryl 2mg 657 732 111%

Getryl 3mg 136 90 66%
Getryl 4mg 787 722 92%
Leflox 250mg 194 137 71%
Leflox 500mg 209 235 112%
LEVLOX IV 32 20 63%
Product Target Achievement Achievement %
Rovista 10mg 243 183 75%
Rovista 20mg 33 27 82%
Rovista 5mg 221 166 75%

Tasmi 20mg 30 81 270%
Tasmi 40mg 100 103 103%
Tasmi 80mg 08 11 138%
Total
2,955,364 3,038,338 103%
JANUARY BRAND CONTRIBUTION
Ezita Tasmi
Avestalo 1.94% 2.44% Empiget
0.17% 23.54% Empiget
Leflox Gabica
6.54% Getryl
Rovista
Rovista
20.72% Leflox
Tasmi
Ezita
Avestalo
Gabica
Getryl
22.55%
22.09%
TOP 5 TOWNS / INSTITUTIONS
Town / Institution Value
558,839.63
Kalmunai
386,241.80
Trincomalee
336,708.92
Akkaraipattu
304,271.51
Batticaloa
279,257.36
Sammanthurai
S.K.JEELAN BATTICALOA
800000
700000
600000
500000
400000
2021
300000 2022
2023
200000
100000
0
August September October November December January
APEX AMPARA
2000000
1864795
1800000 1747022
1611569 1582283
1600000 1542162
1498991
1400000
1200000
2021
1000000 893687 2022
800000 2023
600000
400000
776616
754264
845266
971278
903380
200000
0
L.M.G TRINCOMALEE
1200000
1000000
797952
800000
676028
621340 2021
600000 557173 572100
2022
2023
393113
400000
200536
200000
1017553
1052472
554790
531758
571572
0
AVESTALO 10MG GOLM
100%
12
10
10
6
2021
4 2022
2023
2
0
1

EMPIGET 10 GOLM -
8%
600
532
500 485
461
444
398
400
300 269
2021
2022
200
2023
100
49
11
51
40
14
32
0
EMPIGET 25 GOLM
500%
120
110
100
80
60
2021
40 2022
2023
17 18
20 15
10 9
3
21
10
38
13
0 9
EZITA 10MG GOLM
19%
200
180178
180 171
160 149
140
120 113 116
2021
100 2022
87
80 2023
60
40
20
152
102
171
98
72
0
GABICA 100MG GOLM
-5%
140
120
100
78
80
68 67 68
61 64
58 2021
60
2022
40 2023
20
116
113
62
55
76
0
GABICA 150 GOLM
-43%
400
352
350
315
303 304
300
271
250 240
200
171
150 2021
2022
100 2023
50
171
306
146
245
320
0
GABICA 50MG GOLM
9%
350
300
266
258
250
221 218
199
200
150 142 2021

109
2022
100 2023
50
233
215
302
223
234
0
GABICA 75MG GOLM
12%
350
300 292
257
250 230 229 235
200 188
160
150 2021
2022
100 2023
50
220
264
314
306
248
0
GETRYL 1MG GOLM
-22%
350
307
300 287
250 250
250 238
223 219
200
2021
2022
150 2023
100
50
283
290
266
286
290
0
GETRYL 2 GOLM
16%
1000
900
810
800
732
700
631
600 585 578
517
493 2021
500 2022
400 2023
300
200
100
672
895
781
774
744
0
GETRYL 3MG GOLM
-49%
250
200
179
150 144
139
2021
116 2022
110
2023
100 90
74
50
203
149
169
103
154
0
GETRYL 4MG GOLM
-14%
1400
1200
1000
848
801 801
800 755
722 2021
2022
600 551 560
2023
400
200
1187
975
971
800
916
0
LEFLOX 250MG GOLM
-58%
400
350 334
300
264
250 229 233
210
195
200
2021
150 137 2022
2023
100
50
164
248
258
218
185
0
LEFLOX 500MG GOLM
-31%
400
344 341 343
350
300 282
264
250 235
200
2021
147
150 2022
2023
100
50
230
272
182
268
87
0
LEFLOX IV GOLM
200%
50
45
40
35
30
24 25
25
20
20 2021
16
15 2022
2023
10 8
5
0 0
20
30
25
45
0
0

ROVISTA 5MG GOLM
31%
250
224
200 182
166
150
130 126
104 110
100 2021
2022
50 2023
171
194
177
222
162
0
ROVISTA 10MG GOLM
40%
300
250
199
200 183
159
150 144
130
110 2021
99
100 2022
2023
50
153
173
274
181
156
0
GOL
ROVISTA 20MG M -
6%
100
90
80
70
60
50
40 33 2021
29
30 25 27 2022
20 16 2023
13 13
10
86
27
29
19
29
0
TASMI 20MG GOLM
39%
160 149
140
120
100
81
80
57 58 2021
60 48
44 40 2022
40 2023
20
147
38
75
84
43
0
TASMI 40MG GOLM
-53%
300
250
220 217
200
174
155
150
119 120 2021
103 2022
100
2023
50
252
212
194
228
149
0
TASMI 80MG GOLM
-42%
20 19
18
18 17
16
14
12 11
10 10
10
8 2021
7
2022
6 2023
4
2
17
14
12
0
9

TERRITORY AUDIT
Specialty No. in the List No of Met Calls No of Missed Calls
Without Repeats
VP 19 16 3
PEAD 10 09 1
GP 84 75 09
VS 13 12 1
NuroSur 1 1 -
Uro 2 2 -
NURO 2 2 -
DER 3 3 -
ENT 3 3 -
Chest 3 3 -
Oth 3 3 -
Endo 2 2 -
Rheu 2 2 -
Nephro 1 1 -
Total 158 145 13
COMPETITOR ACTIVITY
 Mega Pharma Sponsored ACP Conference in USA (2021), DR.Arulmoli for EMZIN
 CCL Sponsored 400000/- to Dr.Arulmoli for JARDY
 CCL Sponsored an accommodation for ENDO Session (2021) to Dr.Tharshini (Endo)
For JARDY and SITA
 Zydus Sponsored Malaysia Trip to Dr.Ramesh (VP) For Zyrova
 JL Morrison Conducted a CME to Dr.Yusup (VP) (Nindavur) for EMPAMOR

Umesh - Presentation - Jan 2023

Uploaded by

Copyright:

Available Formats

Umesh - Presentation - Jan 2023

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Umesh - Presentation - Jan 2023

Uploaded by

Copyright:

Available Formats

MONTHLY SALES

Avestalo 10mg 05 10 200%

Getryl 1mg 268 238 89%

Getryl 2mg 657 732 111%

Rovista 10mg 243 183 75%

Rovista 20mg 33 27 82%

Rovista 5mg 221 166 75%

Tasmi 40mg 100 103 103%

Tasmi 80mg 08 11 138%

Town / Institution Value

August September October November December January

150 142 2021

August September October November December January

August September October November December January

You might also like

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.